NCT00109057View on ClinicalTrials.gov

An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 1998

Study Completion Date

February 29, 2004

Conditions
Cancer
Interventions
DRUG

Avastin (bevacizumab)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY